NRs utilize a mutp53‐binding peptide (MBP) for specific recognition and a cationic lipid (DOTAP) to induce autophagosome formation, facilitating the targeted autophagic degradation of mutp53. This enhances therapeutic efficacy in p53‐mutated cancer cells. The gene discussed is TP53; the disease is cancer.